Related references
Note: Only part of the references are listed.Long-term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program
Josemir W. Sander et al.
EPILEPSIA (2022)
Efficacy of cenobamate for uncontrolled focal seizures in patients with previous epilepsy-related surgery: Post hoc analysis of a phase 3, multicenter, open-label study
Bassel Abou-Khalil et al.
EPILEPSY RESEARCH (2022)
Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
Pavel Klein et al.
NEUROLOGY (2022)
Successful treatment of adult Dravet syndrome patients with cenobamate
Konstantin L. Makridis et al.
EPILEPSIA (2022)
Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations
Michael C. Smith et al.
NEUROLOGY AND THERAPY (2022)
Effectiveness and safety of adjunctive cenobamate for focal seizures in adults with developmental disability treated in clinical practice
Gregory S. Connor et al.
EPILEPSY & BEHAVIOR REPORTS (2022)
Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications
William E. Rosenfeld et al.
EPILEPSIA (2021)
Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label study
Michael R. Sperling et al.
EPILEPSIA (2021)
The ups and downs of alkyl-carbamates in epilepsy therapy: How does cenobamate differ?
Wolfgang Loescher et al.
EPILEPSIA (2021)
Long-term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open-label extension of a randomized clinical study
Jacqueline A. French et al.
EPILEPSIA (2021)
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
Gregory L. Krauss et al.
LANCET NEUROLOGY (2020)
Clinical risk factors in SUDEP A nationwide population-based case-control study
Olafur Sveinsson et al.
NEUROLOGY (2020)
Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study
Michael R. Sperling et al.
EPILEPSIA (2020)
Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures
Steve S. Chung et al.
NEUROLOGY (2020)
Cenobamate (XCOPRI): Can preclinical and clinical evidence provide insight into its mechanism of action?
Michelle Guignet et al.
EPILEPSIA (2020)
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multi-centre, double-blind, randomised, placebo-controlled, dose-response trial (vol 19, pg 38, 2020)
G. L. Krauss et al.
LANCET NEUROLOGY (2020)
Effects of cenobamate (YKP3089), a newly developed anti-epileptic drug, on voltage-gated sodium channels in rat hippocampal CA3 neurons
Michiko Nakamura et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs A 30-Year Longitudinal Cohort Study
Zhibin Chen et al.
JAMA NEUROLOGY (2018)
Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology
Robert S. Fisher et al.
EPILEPSIA (2017)
ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology
Ingrid E. Scheffer et al.
EPILEPSIA (2017)
What can we do for people with drug-resistant epilepsy? The 2016 Wartenberg Lecture
Jerome Engel
NEUROLOGY (2016)
Resective Epilepsy Surgery for Drug-Resistant Focal Epilepsy A Review
Barbara C. Jobst et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Assessing the quality of epilepsy care with an electronic patient record
Mary Fitzsimons et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2013)
Focal epilepsies in adult patients attending two epilepsy centers: Classification of drug-resistance, assessment of risk factors, and usefulness of new antiepileptic drugs
Isabella Gilioli et al.
EPILEPSIA (2012)
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
Patrick Kwan et al.
EPILEPSIA (2010)
A graded system to categorize drug-resistant epilepsy
Juan Gomez-Alonso et al.
EPILEPSIA (2010)
Long-term seizure outcome of surgery versus no surgery for drug-resistant partial epilepsy: A review of controlled studies
Dieter Schmidt et al.
EPILEPSIA (2009)
Quantifying the response to antiepileptic drugs
Yitzhak Schiller et al.
NEUROLOGY (2008)
Experimental and clinical evidence for loss of effect (tolerance) during prolonged treatment with antiepileptic drugs
Wolfgang Loescher et al.
EPILEPSIA (2006)
Sudden unexpected death in epilepsy: A review of incidence and risk factors
T Tomson et al.
EPILEPSIA (2005)
Seizure outcome after temporal lobectomy for temporal lobe epilepsy - A Kaplan-Meier survival analysis
N Foldvary et al.
NEUROLOGY (2000)
Early identification of refractory epilepsy.
P Kwan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
